435 related articles for article (PubMed ID: 16422840)
21. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.
Mulhall JP; McLaughlin TP; Harnett JP; Scott B; Burhani S; Russell D
J Sex Med; 2005 Nov; 2(6):848-55. PubMed ID: 16422809
[TBL] [Abstract][Full Text] [Related]
22. Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors.
Tolrà JR; Campaña JMC; Ciutat LF; Miranda EF
J Sex Med; 2006 Sep; 3(5):901-909. PubMed ID: 16942534
[TBL] [Abstract][Full Text] [Related]
23. Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States.
Sharlip ID; Shumaker BP; Hakim LS; Goldfischer E; Natanegara F; Wong DG
J Sex Med; 2008 Mar; 5(3):716-25. PubMed ID: 18304286
[TBL] [Abstract][Full Text] [Related]
24. Timing of dose relative to sexual intercourse attempt in previous sildenafil citrate users treated with tadalafil.
Glina S; Sotomayor M; Gatchalian E; Yaman O; Dyachkova Y; Markey C; Kopernicky V
J Sex Med; 2006 Mar; 3(2):309-19. PubMed ID: 16490025
[TBL] [Abstract][Full Text] [Related]
25. Emotional changes in men treated with sildenafil citrate for erectile dysfunction: a double-blind, placebo-controlled clinical trial.
Moncada I; Martínez-Jabaloyas JM; Rodriguez-Vela L; Gutiérrez PR; Giuliano F; Koskimaki J; Farmer IS; Renedo VP; Schnetzler G
J Sex Med; 2009 Dec; 6(12):3469-77. PubMed ID: 19796051
[TBL] [Abstract][Full Text] [Related]
26. Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.
Buvat J; Büttner H; Hatzimouratidis K; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
J Sex Med; 2013 Jun; 10(6):1592-602. PubMed ID: 23551622
[TBL] [Abstract][Full Text] [Related]
27. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
[TBL] [Abstract][Full Text] [Related]
28. Quality of erections in men treated with flexible-dose sildenafil for erectile dysfunction: multicenter trial with a double-blind, randomized, placebo-controlled phase and an open-label phase.
Kadioglu A; Grohmann W; Depko A; Levinson IP; Sun F; Collins S
J Sex Med; 2008 Mar; 5(3):726-34. PubMed ID: 18086165
[TBL] [Abstract][Full Text] [Related]
29. Impact of erectile dysfunction on confidence, self-esteem and relationship satisfaction after 9 months of sildenafil citrate treatment.
Althof SE; O'Leary MP; Cappelleri JC; Crowley AR; Tseng LJ; Collins S
J Urol; 2006 Nov; 176(5):2132-7. PubMed ID: 17070276
[TBL] [Abstract][Full Text] [Related]
30. Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study.
Fusco F; Sicuteri R; Rossi A; Kontodimas S; Haro JM; Imbimbo C; Mirone V;
Asian J Androl; 2009 Sep; 11(5):629-37. PubMed ID: 19701217
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.
Goldstein I; Kim E; Steers WD; Pryor JL; Wilde DW; Natanegara F; Wong DG; Ahuja S
J Sex Med; 2007 Jan; 4(1):166-175. PubMed ID: 17233782
[TBL] [Abstract][Full Text] [Related]
32. [Oral tadalafil on alternate days for erectile dysfunction that fails to respond to on-demand sildenafil: a report of 15 cases].
Du Q; Gu LX; Miao Y; Xing X; Pan BC; Song YS; Wu B
Zhonghua Nan Ke Xue; 2013 Apr; 19(4):337-9. PubMed ID: 23678714
[TBL] [Abstract][Full Text] [Related]
33. A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction.
Govier F; Potempa AJ; Kaufman J; Denne J; Kovalenko P; Ahuja S
Clin Ther; 2003 Nov; 25(11):2709-23. PubMed ID: 14693299
[TBL] [Abstract][Full Text] [Related]
34. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
[TBL] [Abstract][Full Text] [Related]
35. Sildenafil citrate 100 mg starting dose in men with erectile dysfunction in an international, double-blind, placebo-controlled study: effect on the sexual experience and reducing feelings of anxiety about the next intercourse attempt.
Loran OB; Ströberg P; Lee SW; Park NC; Kim SW; Tseng LJ; Collins S; Stecher VJ
J Sex Med; 2009 Oct; 6(10):2826-35. PubMed ID: 19817982
[TBL] [Abstract][Full Text] [Related]
36. Improvement in quality of sexual life in female partners of men with erectile dysfunction treated with sildenafil citrate: findings of the Index of Sexual Life (ISL) in a couple study.
Chevret-Méasson M; Lavallée E; Troy S; Arnould B; Oudin S; Cuzin B
J Sex Med; 2009 Mar; 6(3):761-9. PubMed ID: 19143916
[TBL] [Abstract][Full Text] [Related]
37. A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil.
von Keitz A; Rajfer J; Segal S; Murphy A; Denne J; Costigan T; Lockhart D; Beasley CM; Emmick JT
Eur Urol; 2004 Apr; 45(4):499-507; discussion 507-9. PubMed ID: 15041116
[TBL] [Abstract][Full Text] [Related]
38. Ten years of phosphodiesterase type 5 inhibitors in spinal cord injured patients.
Lombardi G; Macchiarella A; Cecconi F; Del Popolo G
J Sex Med; 2009 May; 6(5):1248-58. PubMed ID: 19210710
[TBL] [Abstract][Full Text] [Related]
39. The South Australian couples sildenafil study: double-blind, parallel-group randomized controlled study to examine the psychological and relationship consequences of sildenafil use in couples.
Hundertmark J; Esterman A; Ben-Tovim D; Austin MA; Dougherty M
J Sex Med; 2007 Jul; 4(4 Pt 2):1126-35. PubMed ID: 17627725
[TBL] [Abstract][Full Text] [Related]
40. The effect of tadalafil on psychosocial outcomes in Swedish men with erectile distress: a multicentre, non-randomised, open-label clinical study.
Fugl-Meyer KS; Stothard D; Belger M; Toll A; Berglund O; Eliasson T; Fugl-Meyer AR
Int J Clin Pract; 2006 Nov; 60(11):1386-93. PubMed ID: 17073836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
